StonvexLoading…
StonvexStonvexStonvexCore line items from CITR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|
Revenue | $1.70M | $1.00M | $800.00K |
Operating Income | $-6.48M | $-3.46M | $-5.30M |
Net Income | $-11.90M | $-10.90M | $-6.88M |
EPS (Diluted) | $-0.41 | $-1.37 | $-0.82 |
Total Assets | $8.69M | $9.05M | $5.48M |
Total Liabilities | $6.50M | $4.96M | $2.16M |
Cash & Equivalents | $2.33M | $3.74M | $775.13K |
Free Cash Flow OCF − CapEx | $-2.09M | $-740.91K | $-1.94M |
Shares Outstanding | 66.09M | 52.38M | 6.14M |